查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599268

獸醫治療市場：依產品、動物、給藥途徑和最終用戶 - 全球預測 2025-2030

Veterinary Therapeutics Market by Product (Drug Type, Medicated Feed Additive, Vaccines Type), Animal (Companion Animal, Livestock Animal), Route of Administration, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年獸醫治療市場價值為380.5億美元，預計到2024年將達到407.7億美元，複合年成長率為7.23%，到2030年將達到620.4億美元。

獸醫治療市場包括多種專為獸醫設計的產品，包括藥物、疫苗和診斷工具。由於全球寵物擁有量的增加和對畜產品的需求不斷成長，該市場正在應對通用感染疾病日益流行和對先進動物保健解決方案的需求。獸醫療法被廣泛的最終用戶用來預防、控制和治療疾病，包括寵物飼主、獸醫醫院和畜牧養殖者。影響市場的主要成長要素包括藥物開發的技術發展、動物保健意識的提高以及政府措施的增加。最近的潛在商機在於寵物人性化的成長趨勢、生物製藥的進步以及向獸醫需求未滿足的新興市場的擴張。此外，數位解決方案和遠端醫療在簡化獸醫護理方面具有巨大潛力。然而，市場面臨嚴格的監管政策、高昂的開發成本以及仿冒品的出現等挑戰，這可能會阻礙成長。此外，新興市場缺乏足夠的獸醫基礎設施，限制了市場擴張。創新成熟的領域包括精準醫學、基因組學以及人工智慧在診斷中的應用，這可以提高治療通訊協定的準確性和有效性。另一個有前景的領域是開發永續且環保的治療產品，滿足對環保解決方案不斷成長的需求。該市場的特點是競爭格局，主要製藥公司投資於研究和合作夥伴關係以擴大其產品範圍。為了利用新的商機，相關人員應專注於產品系列多樣化、投資於前沿研究，並根據不斷變化的消費者期望和監管環境調整策略。總體而言，由於持續的技術創新以及動物用藥品在全球健康動態中的重要性的日益認知，獸藥市場有望顯著成長。

主要市場統計
基準年[2023] 380.5億美元
預測年份 [2024] 407.7億美元
預測年份 [2030] 620.4億美元
複合年成長率（%） 7.23%

市場動態：快速發展的獸醫治療市場的關鍵市場洞察

供需的動態交互作用正在改變獸醫治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 飼養的伴同性動物和牲畜數量增加
    • 改善經濟國家的獸醫醫療設施
    • 動物慢性病和意外傷害發生率增加
  • 市場限制因素
    • 獸藥高成本
  • 市場機會
    • 各國新產品核可量增加
    • 活性化新治療藥物開發的研究開發活動
  • 市場挑戰
    • 品管問題

波特的五力策略工具駕馭獸醫治療市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解獸醫治療市場的外部影響

外部宏觀環境因素在塑造獸醫治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解獸藥市場競爭狀況

對獸醫治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣獸醫治療市場供應商的績效評估

FPNV定位矩陣是評估獸醫治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃獸醫治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對獸醫治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 飼養寵物和牲畜的數量增加
      • 改善經濟中的獸醫護理設施
      • 動物慢性病和意外傷害發生率增加
    • 抑制因素
      • 獸藥成本高
    • 機會
      • 經濟中新產品核可增加
      • 加強研發活動以開發新治療方法
    • 任務
      • 品管問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章獸醫治療市場：依產品

  • 藥物類型
    • 發炎（藥
    • 反髒話
    • 寄生劑
  • 醫藥添加劑和飼料添加劑
    • 胺基酸
    • 抗生素
    • 網路藥房
    • 零售藥房
  • 疫苗類型
    • 減毒疫苗
    • 去活化疫苗
    • 重組疫苗

第7章獸醫治療市場：依動物分類

  • 寵物
  • 家畜

第8章獸藥市場：依給藥途徑

  • 口服
  • 胃腸外的
  • 話題

第9章獸醫治療市場：依最終使用者分類

  • 藥局/藥局
  • 獸醫診所
  • 動物醫院

第10章：美洲獸藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太獸藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的獸醫治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Biogenesis Bago SA
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma Unlimited
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Eli Lilly and Company
  • Heska Corporation
  • Hester Biosciences Limited
  • IDEXX Laboratories Inc.
  • ImmuCell Corporation
  • Indian Immunologicals Ltd.
  • Merck & Co. Inc.
  • Neogen Corporation
  • Novartis International AG
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Vetoquinol Group
  • Zoetis, Inc.
Product Code: MRR-034B500303A2

The Veterinary Therapeutics Market was valued at USD 38.05 billion in 2023, expected to reach USD 40.77 billion in 2024, and is projected to grow at a CAGR of 7.23%, to USD 62.04 billion by 2030.

The scope of the veterinary therapeutics market encompasses a wide range of products including pharmaceuticals, vaccines, and diagnostic tools designed for animal health care. Necessitated by the rising global pet ownership and the growing demand for livestock products, this market responds to the increasing prevalence of zoonotic diseases and the need for advanced animal healthcare solutions. Veterinary therapeutics are applied in the prevention, control, and treatment of diseases across a broad spectrum of end-users such as pet owners, veterinary hospitals, and livestock farmers. Key growth factors influencing the market include technological advances in drug development, rising animal healthcare awareness, and increased government initiatives. Recent potential opportunities lie in the growing trend of humanization of pets, the advancement of biopharmaceuticals, and the expansion into emerging markets with underserved veterinary needs. Moreover, digital solutions and telemedicine offer significant potential to streamline veterinary care. However, the market faces challenges such as stringent regulatory policies, high development costs, and the emergence of counterfeit products, which can stifle growth. Additionally, the lack of adequate veterinary infrastructure in developing regions limits market proliferation. Areas ripe for innovation include precision medicine, genomics, and the use of AI in diagnostics, which can enhance the accuracy and efficacy of treatment protocols. Another promising area is the development of sustainable and environmentally friendly therapeutic products, catering to the increasing demand for eco-conscious solutions. The market is characterized by a competitive landscape with major pharmaceutical companies investing in research and partnerships to expand their product offerings. To capitalize on emerging opportunities, stakeholders should focus on diversifying product portfolios, investing in cutting-edge research, and aligning strategies with evolving consumer expectations and regulatory landscapes. Overall, the veterinary therapeutics market is poised for substantial growth driven by continuous innovation and the expanding recognition of the importance of animal health in global health dynamics.

KEY MARKET STATISTICS
Base Year [2023] USD 38.05 billion
Estimated Year [2024] USD 40.77 billion
Forecast Year [2030] USD 62.04 billion
CAGR (%) 7.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Therapeutics Market

The Veterinary Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Improving veterinary care facilities in economies
    • Rising incidence of chronic diseases and accidental injuries in animals
  • Market Restraints
    • High cost of veterinary therapeutics
  • Market Opportunities
    • Growing new product approvals in economies
    • Increasing R&D activities to develop new therapeutics
  • Market Challenges
    • Issues with quality management

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Therapeutics Market

A detailed market share analysis in the Veterinary Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Therapeutics Market

A strategic analysis of the Veterinary Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Unlimited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories Inc., ImmuCell Corporation, Indian Immunologicals Ltd., Merck & Co. Inc., Neogen Corporation, Novartis International AG, Nutreco N.V., Phibro Animal Health Corporation, Vetoquinol Group, and Zoetis, Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Drug Type, Medicated Feed Additive, and Vaccines Type. The Drug Type is further studied across Anti-Inflammatory, Anti-Invectives, and Parasiticides. The Medicated Feed Additive is further studied across Amino Acids, Antibiotics, Online Pharmacy, and Retail Pharmacy. The Vaccines Type is further studied across Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines.
  • Based on Animal, market is studied across Companion Animal and Livestock Animal.
  • Based on Route of Administration, market is studied across Oral, Parenteral, and Topical.
  • Based on End User, market is studied across Pharmacies & Drug Store, Veterinary Clinic, and Veterinary Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Improving veterinary care facilities in economies
      • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of veterinary therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing new product approvals in economies
      • 5.1.3.2. Increasing R&D activities to develop new therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Issues with quality management
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Therapeutics Market, by Product

  • 6.1. Introduction
  • 6.2. Drug Type
    • 6.2.1. Anti-Inflammatory
    • 6.2.2. Anti-Invectives
    • 6.2.3. Parasiticides
  • 6.3. Medicated Feed Additive
    • 6.3.1. Amino Acids
    • 6.3.2. Antibiotics
    • 6.3.3. Online Pharmacy
    • 6.3.4. Retail Pharmacy
  • 6.4. Vaccines Type
    • 6.4.1. Attenuated Vaccines
    • 6.4.2. Inactivated Vaccines
    • 6.4.3. Recombinant Vaccines

7. Veterinary Therapeutics Market, by Animal

  • 7.1. Introduction
  • 7.2. Companion Animal
  • 7.3. Livestock Animal

8. Veterinary Therapeutics Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral
  • 8.4. Topical

9. Veterinary Therapeutics Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmacies & Drug Store
  • 9.3. Veterinary Clinic
  • 9.4. Veterinary Hospital

10. Americas Veterinary Therapeutics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Therapeutics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Therapeutics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Biogenesis Bago SA
  • 2. Biovac Ltd.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Ceva Sante Animale
  • 5. Chanelle Pharma Unlimited
  • 6. Dechra Pharmaceuticals PLC
  • 7. Elanco Animal Health Incorporated
  • 8. Eli Lilly and Company
  • 9. Heska Corporation
  • 10. Hester Biosciences Limited
  • 11. IDEXX Laboratories Inc.
  • 12. ImmuCell Corporation
  • 13. Indian Immunologicals Ltd.
  • 14. Merck & Co. Inc.
  • 15. Neogen Corporation
  • 16. Novartis International AG
  • 17. Nutreco N.V.
  • 18. Phibro Animal Health Corporation
  • 19. Vetoquinol Group
  • 20. Zoetis, Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INVECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACIES & DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 327. VETERINARY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023